Voloridge Investment Management’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $427K | Buy |
+20,973
| New | +$427K | ﹤0.01% | 1094 |
|
|
2023
Q2 | – | Sell |
-6,916
| Closed | -$249K | – | 1384 |
|
|
2023
Q1 | $249K | Buy |
+6,916
| New | +$249K | ﹤0.01% | 1290 |
|
|
2022
Q1 | – | Sell |
-132,993
| Closed | -$5.14M | – | 1403 |
|
|
2021
Q4 | $5.14M | Buy |
132,993
+30,847
| +30% | +$1.19M | 0.03% | 720 |
|
|
2021
Q3 | $5.52M | Buy |
+102,146
| New | +$5.52M | 0.04% | 639 |
|
|
2015
Q2 | – | Sell |
-5,952
| Closed | -$2.49M | – | 312 |
|
|
2015
Q1 | $2.49M | Buy |
+5,952
| New | +$2.49M | 0.12% | 168 |
|
|
2014
Q2 | – | Sell |
-7,550
| Closed | -$2M | – | 90 |
|
|
2014
Q1 | $2M | Buy |
+7,550
| New | +$2M | 0.28% | 55 |
|